NORDIC BIOTECH INCENTIVE ApS: Financial statements 2022
CVR: 26277779
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
NORDIC BIOTECH INCENTIVE ApS (CVR 26277779) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -17,993 and a net result of DKK -2,261,727 compared with DKK -338,359 the year before. Equity in the 2022 report amounted to DKK 1,718,456. The solvency ratio was 99.1%.
- Gross Profit
- DKK -17,993
- Profit/Loss
- DKK -2,261,727
- Equity
- DKK 1,718,456
- Total Assets
- DKK 1,734,457
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -18K | -2.3M | 1.7M | 0 |
| 2021 | - | -15K | -338K | 4M | 0 |
| 2020 | - | -17K | -87K | 4.3M | - |
| 2019 | - | -29K | 624K | 4.4M | - |
| 2018 | - | -43K | -23.1M | 3.8M | 0 |
Official annual report
Keep an eye on NORDIC BIOTECH INCENTIVE ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
NORDIC BIOTECH INCENTIVE ApS has published its annual report for 2021. Gross profit came to DKK -15,250, and the net result was DKK -338,359.
About NORDIC BIOTECH INCENTIVE ApS
NORDIC BIOTECH INCENTIVE ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2001. The company has been dissolved on 30 September 2026. The company was registered under the industry Ikke-finansielle holdingselskaber. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -397,188 and a net result of DKK -719,666 compared with DKK 4,871,034 the year before. Equity in the 2025 report amounted to DKK 5,834,302.